Get started
Author

Greg Ball

Prognostic factors and scoring systems in chronic myelomonocytic leukemia: a retrospective analysis of 213 patients
2002 · Francesco Onida, Hagop M. Kantarjian, et al. · Blood · 392
A phase 2a randomized, double-blind, placebo-controlled, sequential dose-escalation study to evaluate the efficacy and safety of ASP015K, a novel Janus kinase inhibitor, in patients with moderate-to-severe psoriasis
2015 · K. Papp, D. Pariser, et al. · British Journal of Dermatology · 117
PDF
Characteristics and outcome of patients with Philadelphia chromosome negative, bcr/abl negative chronic myelogenous leukemia
2002 · Francesco Onida, Greg Ball, et al. · Cancer · 100
PDF
Active- and placebo-controlled dose-finding study to assess the efficacy, safety, and tolerability of multiple doses of ipragliflozin in patients with type 2 diabetes mellitus
2012 · Vivian A. Fonseca, Ele Ferrannini, et al. · Journal of Diabetes and its Complications · 88
The proteasome inhibitor PS-341 inhibits growth and induces apoptosis in Bcr/Abl-positive cell lines sensitive and resistant to imatinib mesylate.
2003 · Simona Gatto, Barbara Scappini, et al. · PubMed · 76
A phase 2, randomized, double-blind, placebo-controlled trial of clinical activity and safety of subcutaneous Å6 in women with asymptomatic CA125 progression after first-line chemotherapy of epithelial ovarian cancer
2008 · Sharad A. Ghamande, Michael H. Silverman, et al. · Gynecologic Oncology · 49
ABT‐719 for the Prevention of Acute Kidney Injury in Patients Undergoing High‐Risk Cardiac Surgery: A Randomized Phase 2b Clinical Trial
2016 · Peter A. McCullough, Elliott Bennett‐Guerrero, et al. · Journal of the American Heart Association · 43
Contribution of β-2 microglobulin levels to the prognostic stratification of survival in patients with myelodysplastic syndrome (MDS)
2003 · Simona Gatto, Greg Ball, et al. · Blood · 42
Absence of Neuroplastin-65 Affects Synaptogenesis in Mouse Inner Hair Cells and Causes Profound Hearing Loss
2016 · Leanne Carrott, Michael R. Bowl, et al. · Journal of Neuroscience · 37
PDF
A Bayesian Exposure-Time Method for Clinical Trial Safety Monitoring With Blinded Data
2016 · Patrick M. Schnell, Greg Ball · Therapeutic Innovation & Regulatory Science · 23
Aggregate Safety Assessment Planning for the Drug Development Life-Cycle
2021 · Barbara A. Hendrickson, William Wang, et al. · Therapeutic Innovation & Regulatory Science · 21
Continuous safety monitoring for randomized controlled clinical trials with blinded treatment information
2011 · Greg Ball, Linda B. Piller, et al. · Contemporary Clinical Trials · 21
A Framework for Safety Evaluation Throughout the Product Development Life-Cycle
2019 · Greg Ball, Tjark Reblin, et al. · Therapeutic Innovation & Regulatory Science · 19
Continuous safety monitoring for randomized controlled clinical trials with blinded treatment information
2011 · Greg Ball · Contemporary Clinical Trials · 18
Continuous safety monitoring for randomized controlled clinical trials with blinded treatment information
2011 · Greg Ball, Linda B. Piller · Contemporary Clinical Trials · 16
Acute Lymphoblastic Leukemia in Elderly Patients: The Philadelphia Chromosome May Not Be a Significant Adverse Prognostic Factor
2002 · Mihaela Onciu, Carlos Bueso-Ramos, et al. · American Journal of Clinical Pathology · 13
Blinded Safety Signal Monitoring for the FDA IND Reporting Final Rule
2016 · Greg Ball, Patrick M. Schnell · ICSA book series in statistics · 11
Clinical Trial Drug Safety Assessment for Studies and Submissions Impacted by COVID-19
2020 · Mary Nilsson, Brenda Crowe, et al. · Statistics in Biopharmaceutical Research · 10
PDF
Bridging blinded and unblinded analysis for ongoing safety monitoring and evaluation
2019 · Li-An Lin, Yilei Zhan, et al. · Contemporary Clinical Trials · 10
Use of thin-section, multidetector row helical CT images for coronal oblique reformations for optimal visualization of structures in the hepatoduodenal ligament
2004 · S. C. Faria, E. P. Tamm, et al. · Abdominal Imaging · 10
Global Regulatory Landscape for Aggregate Safety Assessments: Recent Developments and Future Directions
2020 · Greg Ball, Raffael Kurek, et al. · Therapeutic Innovation & Regulatory Science · 9
PDF
Interdisciplinary Safety Evaluation for Learning and Decision-Making
2021 · Greg Ball, Barbara A. Hendrickson, et al. · Therapeutic Innovation & Regulatory Science · 8
Bayesian Meta-analysis of Safety Outcomes Using Blinded Clinical Trial Data
2020 · Emily Goren, Li-An Lin, et al. · Therapeutic Innovation & Regulatory Science · 7
Statistical Practices of Safety Monitoring: An Industry Survey
2018 · Michael W. Colopy, Robert Gordon, et al. · Therapeutic Innovation & Regulatory Science · 6
In vitro effects of STI571-containing drug combinations on growth of Ph-posittve myelogenous leukemia-derived cells
2000 · Barbara Scappini, Francesco Onida, et al. · Blood · 6
Works count: 42
Citation count: 1,175
H-index: 15
I10-index: 20
Year
Topic
Type